SCHEMBL17975327

SCHEMBL17975327

Cc1cc(C)nc(NC(=N)NCc2cccnc2)n1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.52
▸ HSD17B10 Q99714 2/20 0.52
▸ CACNA1B Q00975 1/20 0.51
▸ APBA1 Q02410 1/20 0.51
▸ RECQL P46063 1/20 0.50
▸ MAPT P10636 1/20 0.50
▸ ALDH1A1 P00352 4/20 0.49
▸ MEN1 O00255 1/20 0.48
▸ KMT2A Q03164 1/20 0.48
▸ HPGD P15428 2/20 0.47
▸ SMN1; SMN2 Q16637 3/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ LMNA P02545 2/20 0.46
▸ GLA P06280 1/20 0.46
▸ POLB P06746 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CTSL P07711 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5923306 0.85 ALDH1A1 (0.48) KDM4ERECQLMAPTALDH1A1MEN1
SCHEMBL5923585 0.78 AOC3 (0.46) ALDH1A1MEN1KMT2ALMNA
SCHEMBL5923052 0.77 VCP (0.46) KDM4EMAPTALDH1A1MEN1KMT2A
SCHEMBL14289021 0.77 ALDH1A1 (0.60) RECQLMAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL5923053 0.75 EPHX2 (0.44) MEN1KMT2ASMN1; SMN2HTT
SCHEMBL10753424 0.74 ALDH1A1 (0.67) RECQLMAPTALDH1A1KMT2AHPGD
SCHEMBL2801059 0.74 ALDH1A1 (0.48) KDM4EALDH1A1MEN1KMT2AHPGD
SCHEMBL5923073 0.74 RAB9A (0.48) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL13450756 0.74 ALDH1A1 (0.64) RECQLMAPTALDH1A1KMT2ASMN1; SMN2
Hydrochloric Acid SCHEMBL11333270 0.73 ALDH1A1 (0.65) RECQLMAPTALDH1A1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160374997-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-12-29 — — US disclosed
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-08-04 — — US disclosed
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM 2016-08-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160374997-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS AARS1, EPRS1, EEF1G KDM4E 1642/4885HSD17B10 3014/4885CACNA1B 4774/4885
US-20160220510-A1 ANTIBIOTIC COMPOUNDS THAT INHIBIT BACTERIAL PROTEIN SYNTHESIS AARS1, EPRS1, EEF1G KDM4E 1642/4885HSD17B10 3014/4885CACNA1B 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback